vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $950.5M, roughly 1.5× Astrana Health, Inc.). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs 0.7%, a 0.8% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 6.4%). SELECT MEDICAL HOLDINGS CORP produced more free cash flow last quarter ($5.2M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 2.8%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
ASTH vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.4B |
| Net Profit | $6.6M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 4.6% |
| Net Margin | 0.7% | 1.4% |
| Revenue YoY | 42.9% | 6.4% |
| Net Profit YoY | 184.4% | 225.7% |
| EPS (diluted) | $0.12 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.4B | ||
| Q3 25 | $956.0M | $1.4B | ||
| Q2 25 | $654.8M | $1.3B | ||
| Q1 25 | $620.4M | $1.4B | ||
| Q4 24 | $665.2M | $1.3B | ||
| Q3 24 | $478.7M | $1.3B | ||
| Q2 24 | $486.3M | $1.3B | ||
| Q1 24 | $404.4M | $1.3B |
| Q4 25 | $6.6M | $20.2M | ||
| Q3 25 | $373.0K | $28.8M | ||
| Q2 25 | $9.4M | $40.6M | ||
| Q1 25 | $6.7M | $56.7M | ||
| Q4 24 | $-7.8M | $-16.1M | ||
| Q3 24 | $16.1M | $55.6M | ||
| Q2 24 | $19.2M | $77.6M | ||
| Q1 24 | $14.8M | $96.9M |
| Q4 25 | 1.9% | 4.6% | ||
| Q3 25 | 2.0% | 5.4% | ||
| Q2 25 | 3.1% | 6.5% | ||
| Q1 25 | 3.3% | 8.3% | ||
| Q4 24 | 0.1% | 1.6% | ||
| Q3 24 | 5.9% | 4.3% | ||
| Q2 24 | 6.2% | 5.8% | ||
| Q1 24 | 7.5% | 9.0% |
| Q4 25 | 0.7% | 1.4% | ||
| Q3 25 | 0.0% | 2.1% | ||
| Q2 25 | 1.4% | 3.0% | ||
| Q1 25 | 1.1% | 4.2% | ||
| Q4 24 | -1.2% | -1.2% | ||
| Q3 24 | 3.4% | 4.4% | ||
| Q2 24 | 3.9% | 6.1% | ||
| Q1 24 | 3.7% | 7.3% |
| Q4 25 | $0.12 | $0.17 | ||
| Q3 25 | $0.01 | $0.23 | ||
| Q2 25 | $0.19 | $0.32 | ||
| Q1 25 | $0.14 | $0.44 | ||
| Q4 24 | $-0.14 | $-0.12 | ||
| Q3 24 | $0.33 | $0.43 | ||
| Q2 24 | $0.40 | $0.60 | ||
| Q1 24 | $0.31 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $26.5M |
| Total DebtLower is stronger | — | $1.8B |
| Stockholders' EquityBook value | $779.3M | $1.7B |
| Total Assets | $2.2B | $5.9B |
| Debt / EquityLower = less leverage | — | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $26.5M | ||
| Q3 25 | $463.4M | $60.1M | ||
| Q2 25 | $342.1M | $52.3M | ||
| Q1 25 | $260.9M | $53.2M | ||
| Q4 24 | $290.8M | $59.7M | ||
| Q3 24 | $350.3M | $191.5M | ||
| Q2 24 | $327.7M | $111.2M | ||
| Q1 24 | $337.3M | $92.6M |
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.8B |
| Q4 25 | $779.3M | $1.7B | ||
| Q3 25 | $775.5M | $1.7B | ||
| Q2 25 | $765.5M | $1.7B | ||
| Q1 25 | $745.4M | $1.7B | ||
| Q4 24 | $712.7M | $1.7B | ||
| Q3 24 | $704.6M | $1.9B | ||
| Q2 24 | $678.9M | $1.4B | ||
| Q1 24 | $653.5M | $1.4B |
| Q4 25 | $2.2B | $5.9B | ||
| Q3 25 | $2.2B | $5.7B | ||
| Q2 25 | $1.4B | $5.7B | ||
| Q1 25 | $1.3B | $5.7B | ||
| Q4 24 | $1.4B | $5.6B | ||
| Q3 24 | $1.3B | $8.0B | ||
| Q2 24 | $1.3B | $7.9B | ||
| Q1 24 | $1.2B | $7.9B |
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× | ||
| Q1 24 | — | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $64.3M |
| Free Cash FlowOCF − Capex | $-6.0M | $5.2M |
| FCF MarginFCF / Revenue | -0.6% | 0.4% |
| Capex IntensityCapex / Revenue | 0.3% | 4.2% |
| Cash ConversionOCF / Net Profit | -0.44× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $64.3M | ||
| Q3 25 | $10.0M | $175.3M | ||
| Q2 25 | $90.9M | $110.3M | ||
| Q1 25 | $16.6M | $-3.5M | ||
| Q4 24 | $-10.9M | $125.4M | ||
| Q3 24 | $34.0M | $181.0M | ||
| Q2 24 | $23.2M | $278.2M | ||
| Q1 24 | $6.0M | $-66.7M |
| Q4 25 | $-6.0M | $5.2M | ||
| Q3 25 | $7.4M | $122.2M | ||
| Q2 25 | $89.5M | $45.6M | ||
| Q1 25 | $13.6M | $-55.8M | ||
| Q4 24 | $-13.5M | $62.0M | ||
| Q3 24 | $31.7M | $130.3M | ||
| Q2 24 | $20.4M | $222.6M | ||
| Q1 24 | $5.6M | $-119.2M |
| Q4 25 | -0.6% | 0.4% | ||
| Q3 25 | 0.8% | 9.0% | ||
| Q2 25 | 13.7% | 3.4% | ||
| Q1 25 | 2.2% | -4.1% | ||
| Q4 24 | -2.0% | 4.7% | ||
| Q3 24 | 6.6% | 10.2% | ||
| Q2 24 | 4.2% | 17.4% | ||
| Q1 24 | 1.4% | -9.0% |
| Q4 25 | 0.3% | 4.2% | ||
| Q3 25 | 0.3% | 3.9% | ||
| Q2 25 | 0.2% | 4.8% | ||
| Q1 25 | 0.5% | 3.9% | ||
| Q4 24 | 0.4% | 4.8% | ||
| Q3 24 | 0.5% | 4.0% | ||
| Q2 24 | 0.6% | 4.3% | ||
| Q1 24 | 0.1% | 4.0% |
| Q4 25 | -0.44× | 3.19× | ||
| Q3 25 | 26.69× | 6.09× | ||
| Q2 25 | 9.65× | 2.72× | ||
| Q1 25 | 2.48× | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 3.25× | ||
| Q2 24 | 1.21× | 3.59× | ||
| Q1 24 | 0.40× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
